None listed
Conditions
Interventions
Dietary Supplement : Probiotics or Placebo
Capsules, 500mg/capsule, 1 capsule/time, Once a day, Oral administration for 12 weeks
Sponsors
Ildong Bioscience
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Adult men and women aged 20 to 65 2) A person whose BMI is greater than or equal to 25 kg/m2 and less than 30 kg/m2 3) A person who voluntarily agrees to participate in the study and signs an informed consent form for the study
Exclusion criteria
Exclusion criteria: 1) A person who has lost more than 10% of their weight in the three months preceding the screening visit date. 2) A person who has continuously taken drugs or health functional foods that affect weight or body fat reduction one month prior to the registration date of the study subjects - Drugs: anti-obesity drugs, hypoglycemic drugs, insulin drugs, diuretic drugs, antidepressants, corticosteroids, antidiarrheal drugs, contraceptives, and other drugs that affect energy metabolism/glycemia/gastrophobia/weight 3) A person who has undergone surgery or treatment for the purpose of weight loss within the last year 4) A person who has participated in commercial/non-commercial weight loss programs in the last 3 months 5) A person with uncontrolled hypertension (systolic blood pressure greater than 160 mmHg or diastolic blood pressure greater than 100 mmHg) 6) A person with fasting blood sugar above 126 mg/dL, diagnosed with diabetes, or taking oral glycemic drugs or insulin drugs 7) A person whose AST, ALT, and creatine levels exceed twice the normal range 8) Pregnant women, lactating women and those with plans for pregnancy within the next six months 9) A person who is hypersensitive to test products or components contained in test products or is allergic to certain components 10) A person who has been diagnosed and treated for cancer within the last 5 years 11) A person with surgical history within the last 6 months 12) A person diagnosed with autoimmune disease or thyroid disease 13) A person diagnosed with severe cerebrovascular disease (cerebral infarction, cerebral hemorrhage, etc.) or heart disease (angiosis, myocardial infarction, heart failure, arrhythmia, etc.) 14) A person diagnosed with chronic gastrointestinal disorder 15) A person diagnosed with mental illness, central nervous disorder, alcoholism, and eating disorder 16) A person on oral contraceptives 17) A person who participated in another clinical trial or human application test one month before participation in the test 18) A person who is unable to read or whose ability is limited 19) Other persons deemed inappropriate by the research manager to participate in the research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of body fat (assessed by dual-energy x-ray absorptiometry) | — |
Secondary
| Measure | Time frame |
|---|---|
| Change of body fat (assessed by bioelectric impedance analysis);Blood lipid profiles (Adiponectin, Leptin, Triglyceride, Total cholesterol, LDL-cholesterol, HDL-cholesterol , Insulin);Waist-hip ratio;Defecation function test | — |
Countries
Korea, Republic of
Contacts
Public ContactMiji Lee
Research Institute of Medical Nutrition
Outcome results
None listed